Epilepsy News

Xenon phase 3 epilepsy readout 'blows away' expectations, stock soars - Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more than 50% for some patients as it looks to position itself to become the ...

In people with epilepsy, sleeping after a seizure may trigger more seizures - Epileptic seizures alter sleep by prolonging the stage that's central to memory formation, potentially predisposing the brain to "remember" how to trigger subsequent seizures more easily, a small ...

Xenon To Seek Approval of First-in-Class Epilepsy Drug After Exceeding Phase 3 Expectations - Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7%. Xenon Pharmaceuticals believes this is the highest such efficacy ...

From clinical practice to mechanistic insights in ketogenic diets for epilepsy - Ketogenic diet therapies, including the classic ketogenic diet, modified Atkins diet, and low glycaemic index treatment, have shown effectiveness in controlling seizures, in part by shifting ...

Focal treatment-resistant epilepsy symptoms improved with antiseizure medication - Please provide your email address to receive an email when new articles are posted on . Monthly seizure frequency percentage reduction was 68.73% for the entire study cohort. For those followed up in ...

70-Year-Old Drug Could Stop Epilepsy Seizures - Researchers identify prochlorperazine as a potential new treatment for temporal lobe epilepsy by restoring the KCC2 chloride pump in neurons.

Pediatrics in Brevard: Here's what to know about epilepsy, what to do if someone has seizure - More than 3.4 million people in the United States have epilepsy, so it is a relatively common diagnosis. In fact, it is the fourth-most common neurologic condition in the world. November is National ...

Understanding epilepsy: Seven ways to respond to an epileptic seizure - At the forefront of epilepsy research and treatment is the University of Alabama at Birmingham Epilepsy Center, a collaborative initiative between the UAB Department of Neurology and UAB Hospital, ...

What is neurofeedback? Video game-like therapy being used to treat anxiety, ADHD and more - It’s like a gym for your brain. As issues like anxiety, depression and restless sleep have spiked during the pandemic, some people are turning to neurofeedback, a kind of gym for the brain. It’s a ...

Neurofeedback is the newest mental health hack among entrepreneurs. Here’s why - Running a business can be an exhilarating and rewarding journey, but it can also bring a unique set of stressors. While the beginning stages of a business can be exciting and feel full of ...

How Neurofeedback Can Help Troubled Couples Get Back on the Same Wavelength - Dr. David Helfand (left) with a patient. The cap contains 19 electrodes that measure the brain’s electrical activity. Credit: Courtesy When a 10-year romantic relationship ended last spring for ...

Help managing ADHD, anxiety, and depression with Neurofeedback Therapy - SALT LAKE CITY, Utah (Good Things Utah) – for some people, managing symptoms of trauma, anxiety, depression, ADHD, and sleep issues can result in professional after professional all trying ...

Novel neurofeedback technique enhances awareness of mind-wandering - Everyone knows the feeling. You are trying to concentrate on driving or studying, or paying attention in a boring meeting, but suddenly, you realize that you are thinking about something irrelevant to ...

Before status epilepticus in epilepsy patients is attributed to the SARS-CoV-2 vaccination, alternative causes must be ruled out: Status epilepticus after COVID-19 vaccination - No abstract

Levetiracetam vs. valproate: Which antiseizure medication worsens insulin resistance and metabolic health? - No abstract

Seizure-free days as a clinical outcome measure of reduced epilepsy burden: 5-year outcomes with cenobamate treatment - CONCLUSIONS: Participants taking cenobamate who achieved ≥ 90%-< 100% responder rates were seizure-free for nearly 98% of days during the 5 years of the OLE. These results suggest that a high reduction of seizure burden can be achieved and maintained by many people with epilepsy taking cenobamate.

The Burden of Epilepsy in Thailand: Estimating Societal Costs and Quality of Life - CONCLUSION: Direct medical costs were the largest component of total costs. Cost differences were found across age, employment status, residential distance, and seizure control. QOL varied by age and seizure control in PWE and by age and unemployment status in caregivers.

An Infant With Phakomatosis Pigmentovascularis Complicated by Multisystem Damage: Elaborate Care Leads to a Positive Outcome - This report highlights the value of multidisciplinary collaboration, personalized care, dynamic monitoring of seizure activity, and innovative skin management in a 2-month-old with Phakomatosis Pigmentovascularis. In parallel, the nursing team implemented a multidimensional "medical-social-psychological" support model, providing psychological guidance and economic assistance to the family to he...

Genetic spectrum of unexplained neonatal seizures: a single-center study - CONCLUSIONS: Our findings demonstrate a high diagnostic yield of next-generation sequencing (NGS) in unexplained neonatal seizures and underscore its clinical utility in pinpointing treatable conditions and prognosticating severe disorders.

Brain signal irregularity may provide clues to understanding epileptic process - Researchers propose a new method to differentiate signals from the epileptic focus from those recorded in other parts of the brain without the presence of an epileptic seizure. This technique may help detect epilepsy-induced features from these signals much quicker than conventional analysis techniques.

Breakthrough tech enables seizure localization in minutes - New research introduces a novel network analysis technology that uses minimally invasive resting state electrophysiological recordings to localize seizure onset brain regions and predict seizure outcomes in just 10 minutes.

Antidepressant use during pregnancy not linked to epilepsy in children - A new study suggests that antidepressant use by mothers during the first trimester of pregnancy does not increase the chances of epilepsy and seizures in babies.